Same story like IMU and RAD, full steam ahead in the background while the sp remains at all time lows. What better investment opportunity can we ask for, especially when CHM like IMU and RAD are on their way providing real and succesful cancer treatments. Brain cancer is such a terrible type of cancer, even the tiniest progress will make a huge difference for patients and has incredible scientific value.
Yet, the BOT continues to drive the sp down.
GLTA
Ann: Fourth dose cohort initiated in CHM 1101 Phase 1 trial, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 243067 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 14771167 | 22 |
View Market Depth
| Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |